Risk Assessment and Prevention of Falls In Older Community-Dwelling Adults
JAMA doi.10.1001/JAMA.2024.1416, Colon-Emeric,C.S.,et al, 2024
National Randomized Controlled Trial of Virtual House Calls for Parkinson Disease
Neurol 89:1152-1161,1103, Beck, C.A.,et al, 2017
Neurologic Manifestations of E Coli infection - induced Hemolytic-Uremic Syndrome in Adults
Neurol 79:1466-1473, Weissenborn, K.,et al, 2012
Neurologic Complications of Influenza A (H1N1)pdm09
Neurol 79:1474-1481, Khandaker,G.,et al, 2012
A Cohort Study of Early Neurological Consultation by Telemedicince on the Care of Neurological Inpatients
JNNP 75:1031-1035, Craig,J.,et al, 2004
Randomised Controlled Trial of Telemedicine for New Neurological Outpatient Referrals
JNNP 71:63-66, Chua,R.,et al, 2001
Clinical Audit and Neurology
Hopkins. A. , JNNP 55 (Suppl) :19-25., , 1992
Wait Time to See a Neurologist After Referral Among Medicare Participants
Neurol 104:e210217, Lin,C.C.,et al, 2025
Patient Travel Distance to Neurologist Visits
Neurol 101:e1807-e1820, Lin,C.C.,et al, 2023
Telemedicine in Neurology
Neurol 94:30-38,16, Hatcher-Martin, J.M.,et al, 2020
Preparing a Neurology Department for SARS-CoV-2 (COVID-19)
Neurol 94:886-891, Waldman, G.,et al, 2020
Deprescribing in Epilepsy
JAMA Neurol 77:673-674, Terman, S.W.,et al, 2020
The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection
JAMA Neurol 77:679-680, Pleasure, S.J.,et al, 2020
Training in Neurology: Flexibility and Adaptability of a Neurology Training Program at the Epicenter of COVID-19
Neurol 94:e2608-e2614, Agarwal, S.,et al, 2020
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Scoping Review of Prevalence of Neurologic Comorbidities in Patients Hospitalized for COVID-19
Neurol 95:77-84, Herman, C.,et al, 2020
The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders
JAMA Neurol 77:927-928, Bloem, B.R.,et al, 2020
Complications from "Stem Cell Tourism" in Neurology
Ann Neurol 88:661-668, Julian, K.,et al, 2020
A 73-Year-Old Man with Recurrent Aphasia, Headaches, and Confusion
Neurol 95:e2595-e2599, Bose, G.,et al, 2020
Testing the Reflexes
BMJ 366:l4830, Lees, A.J. & Hurwitz, B., 2019
Medical Use of Cannabis in 2019
JAMA 322:974-975, Hill, K.P., 2019
Optic Nerve Head Edema Among Patients Presenting to the Emergency Department
Neurol 90:e373-e379, Sachdeva, V.,et al, 2018
Toxidrome Recognition in Chemical - Weapons Attacks
NEJM 378:1611-1620, Ciottone, G.R., 2018
A Headache of a Diagnosis
NEJM 379:475-479, Stern,R.M.,et al, 2018
Quality Improvement in Neurology: Inpatient and Emergency Care Quality Measure Set
Neurol 89:730-735, Josephson, S.An.,et al, 2017
Clinicopathologic Conference, Aqueductal Stenosis with Hydrocephalus
NEJM 375:2583-2593, Case 40-2016, 2016
Clinical Neurology: Why this Still Matters in the 21st Century
JNNP 86:229-233, Nicholl, D.J. & Appleton, J.P., 2015
Advantages and Limitations of Teleneurology
JAMA Neurol 72:349-354, Wechsler, L.R., 2015
The Importance of Lesbian, Gay, Bisexual and Transgender Health in Neurology
JAMA Neurol 72:855, Rosendale, N. & Josephson, S.A., 2015
Obsessive-Compulsive Disorder
BMJ 348:g2183, Veale, D.,et al, 2014
Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders
Neurol 82:1556-1563, Koppel, B.S.,et al, 2014
Rosai-Dorfman Disease of the Central Nervous System
Medicine 93:165-175, Sandoval-Sus, J.D.,et al, 2014
Teleneurology Applications
Neurol 80:670-676, Wechsler, L.,et al, 2013
Randomized Controlled Clinical Trial of "Virtual House Calls" for Parkinson Disease
JAMA Neurol 70:565-570, Dorsey, E.R.,et al, 2013
Transglutaminase 6 Antibodies in the Diagnosis of Gluten Ataxia
Neurol 80:1740-1745, Hadjivassilou, M.,et al, 2013
Spectrum of Neurologic Complications in Chronic Lymphocytic Leukemia
Clin Lymphoma Myeloma Leuk 12:164-179, Lopes da Silva, R., 2012
Deep Brain Stimulation
JAMA 305:732, Pluta,R.,et al, 2011
Evidence-Based Guideline Update: Plasmapheresis in Neurologic Disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 76:294-300, Cortese,I.,et al, 2011
"Im fine; Im just waiting for my disease" The New and Growing Class of Presymptomatic Patients
Neurol 77:522-523, Kwon, J.M.et al, 2011
Neurological Injury in Adults Treated with Extracorporeal Membrane Oxygenation
Arch Neurol 68:1543-1549, Mateen, F.J.,et al, 2011
A Guide to Imaging for Common Neurological Problems
BMJ 341:388-393, Cohen,A.B., et al, 2010
Risk Factors of Cerebral Vein and Sinus Thrombosis
Front Neurol Neurosci 23:23-54, de Freitas, G.R. & Bogousslavsky, J., 2008
Deep Brain Stimulation
Neurologist 13:237-252, Kem,DS. &Kumar,R., 2007
Plasma Exchange in Neuroimmunological Disorders: Part 2. Treatment of Neuromuscular Disorders
Arch Neurol 63:1066-1071, Lehmann,H.C.,et al, 2006
Autonomic Peripheral Neuropathy
Lancet 365:1259-1270, Freeman,R., 2005
Position Statement Regarding the Use of Embryonic and Adult Human Stem Cells in Biomedical Research
Neurol 64:1679-1680,1675, American academy of Neurology and American Neurological Association, 2005
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Oral Antispastic Drugs in Nonprogressive Neurologic Diseases
Neurol 63:1357-1363, Montane,E.,et al, 2004
Gene Transfer for Neurologic Disease
Neurol 63:2225-2232, Mendell,J.R. &Miller,A., 2004